Insider · CIK 0001327414

Olson William C

Reports to the SEC for 1 company · TARRYTOWN, NY

sec.gov

Transactions

Companies

Filings

CIK

0001327414

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2013-04-04	PROGENICS PHARMACEUTICALS INCNon-Qualified Stock Option (right to buy)A Award	Senior VP, Research and Develo	AAward	+60K sh	$5.03	+$302K	60,000
2012-06-20	PROGENICS PHARMACEUTICALS INCD Disposition to Issuer	Senior VP, Research and Develo	DDisposition to Issuer	−1,230 sh	$8.69	−$10.7K	45,544
2012-03-01	PROGENICS PHARMACEUTICALS INCNon-Qualified Stock Option (right to buy)A Award	Senior VP, Research and Develo	AAward	+50K sh	$9.81	+$491K	50,000
2011-10-03	PROGENICS PHARMACEUTICALS INCM Exercise/Conversion	Senior VP, Research and Develo	MExercise/Conversion	+2,605 sh	$4.62	+$12K	49,130
2011-10-03	PROGENICS PHARMACEUTICALS INCF Tax Payment	Senior VP, Research and Develo	FTax Payment	−2,356 sh	$5.44	−$12.8K	46,774
2011-10-03	PROGENICS PHARMACEUTICALS INCESPP (right to buy)M Exercise/Conversion	Senior VP, Research and Develo	MExercise/Conversion	−2,605 sh	—	—	0
2011-07-01	PROGENICS PHARMACEUTICALS INCM Exercise/Conversion	Senior VP, Research and Develo	MExercise/Conversion	+6,335 sh	$5.46	+$34.6K	51,609
2011-07-01	PROGENICS PHARMACEUTICALS INCF Tax Payment	Senior VP, Research and Develo	FTax Payment	−5,276 sh	$7.40	−$39K	46,333
2011-07-01	PROGENICS PHARMACEUTICALS INCESPP (right to buy)M Exercise/Conversion	Senior VP, Research and Develo	MExercise/Conversion	−6,335 sh	—	—	0
2011-07-01	PROGENICS PHARMACEUTICALS INCNon-Qualified Stock Option (right to buy)A Award	Senior VP, Research and Develo	AAward	+70K sh	—	—	70,000
2011-06-21	PROGENICS PHARMACEUTICALS INCS Sale	Senior VP, Research and Develo	SSale	−2,766 sh	$7.09	−$19.6K	45,080
2011-06-21	PROGENICS PHARMACEUTICALS INCS Sale	Senior VP, Research and Develo	SSale	−106 sh	$7.11	−$753.66	44,974
2011-04-01	PROGENICS PHARMACEUTICALS INCM Exercise/Conversion	Senior VP, Research and Develo	MExercise/Conversion	+2,373 sh	$5.05	+$12K	49,921
2011-04-01	PROGENICS PHARMACEUTICALS INCF Tax Payment	Senior VP, Research and Develo	FTax Payment	−2,075 sh	$6.29	−$13.1K	47,846
2011-04-01	PROGENICS PHARMACEUTICALS INCESPP (right to buy)M Exercise/Conversion	Senior VP, Research and Develo	MExercise/Conversion	−2,373 sh	—	—	0
2011-04-01	PROGENICS PHARMACEUTICALS INCESPP (right to buy)A Award	Senior VP, Research and Develo	AAward	+2,057 sh	—	—	2,057
2011-01-03	PROGENICS PHARMACEUTICALS INCM Exercise/Conversion	Senior VP, Research and Develo	MExercise/Conversion	+2,582 sh	$4.83	+$12.5K	49,655
2011-01-03	PROGENICS PHARMACEUTICALS INCF Tax Payment	Senior VP, Research and Develo	FTax Payment	−2,351 sh	$5.68	−$13.4K	47,304
2011-01-03	PROGENICS PHARMACEUTICALS INCESPP (right to buy)M Exercise/Conversion	Senior VP, Research and Develo	MExercise/Conversion	−2,582 sh	—	—	0
2011-01-03	PROGENICS PHARMACEUTICALS INCESPP (right to buy)D Disposition to Issuer	Senior VP, Research and Develo	DDisposition to Issuer	+5,308 sh	—	—	5,308
2010-10-01	PROGENICS PHARMACEUTICALS INCM Exercise/Conversion	Senior VP, Research and Develo	MExercise/Conversion	+6,915 sh	$4.32	+$29.9K	53,125
2010-10-01	PROGENICS PHARMACEUTICALS INCF Tax Payment	Senior VP, Research and Develo	FTax Payment	−6,254 sh	$5.08	−$31.8K	46,871
2010-10-01	PROGENICS PHARMACEUTICALS INCESPP (right to buy)M Exercise/Conversion	Senior VP, Research and Develo	MExercise/Conversion	−6,915 sh	—	—	0
2010-10-01	PROGENICS PHARMACEUTICALS INCESPP (right to buy)A Award	Senior VP, Research and Develo	AAward	+2,373 sh	—	—	2,373
2010-07-01	PROGENICS PHARMACEUTICALS INCM Exercise/Conversion	Senior VP, Research and Develo	MExercise/Conversion	+2,541 sh	$4.44	+$11.3K	38,274
2010-07-01	PROGENICS PHARMACEUTICALS INCF Tax Payment	Senior VP, Research and Develo	FTax Payment	−2,282 sh	$5.35	−$12.2K	35,992
2010-07-01	PROGENICS PHARMACEUTICALS INCA Award	Senior VP, Research and Develo	AAward	+10K sh	—	—	45,992
2010-07-01	PROGENICS PHARMACEUTICALS INCESPP (right to buy)M Exercise/Conversion	Senior VP, Research and Develo	MExercise/Conversion	−2,541 sh	—	—	0
2010-07-01	PROGENICS PHARMACEUTICALS INCESPP (right to buy)A Award	Senior VP, Research and Develo	AAward	+2,187 sh	—	—	2,187
2010-07-01	PROGENICS PHARMACEUTICALS INCNon-Qualified Stock Option (right to buy)A Award	Senior VP, Research and Develo	AAward	+30K sh	—	—	30,000
2010-06-22	PROGENICS PHARMACEUTICALS INCS Sale	Senior VP, Research and Develo	SSale	−2,364 sh	$5.80	−$13.7K	35,494
2010-04-01	PROGENICS PHARMACEUTICALS INCM Exercise/Conversion	Senior VP, Research and Develo	MExercise/Conversion	+2,490 sh	$4.56	+$11.3K	40,124
2010-04-01	PROGENICS PHARMACEUTICALS INCF Tax Payment	Senior VP, Research and Develo	FTax Payment	−2,266 sh	$5.36	−$12.1K	37,858
2010-04-01	PROGENICS PHARMACEUTICALS INCESPP (right to buy)M Exercise/Conversion	Senior VP, Research and Develo	MExercise/Conversion	−2,490 sh	—	—	0
2010-04-01	PROGENICS PHARMACEUTICALS INCESPP (right to buy)A Award	Senior VP, Research and Develo	AAward	+2,117 sh	—	—	2,117
2010-01-04	PROGENICS PHARMACEUTICALS INCM Exercise/Conversion	Senior VP, Research and Develo	MExercise/Conversion	+2,989 sh	$3.78	+$11.3K	40,147
2010-01-04	PROGENICS PHARMACEUTICALS INCF Tax Payment	Senior VP, Research and Develo	FTax Payment	−2,720 sh	$4.45	−$12.1K	37,427
2010-01-04	PROGENICS PHARMACEUTICALS INCESPP (right to buy)M Exercise/Conversion	Senior VP, Research and Develo	MExercise/Conversion	−2,989 sh	—	—	0
2010-01-04	PROGENICS PHARMACEUTICALS INCESPP (right to buy)A Award	Senior VP, Research and Develo	AAward	+6,370 sh	—	—	6,370
2009-10-01	PROGENICS PHARMACEUTICALS INCM Exercise/Conversion	Senior VP, Research and Develo	MExercise/Conversion	+2,533 sh	$4.26	+$10.8K	39,215
2009-10-01	PROGENICS PHARMACEUTICALS INCF Tax Payment	Senior VP, Research and Develo	FTax Payment	−2,305 sh	$5.01	−$11.5K	36,910
2009-10-01	PROGENICS PHARMACEUTICALS INCESPP (right to buy)M Exercise/Conversion	Senior VP, Research and Develo	MExercise/Conversion	−2,533 sh	—	—	0
2009-10-01	PROGENICS PHARMACEUTICALS INCESPP (right to buy)A Award	Senior VP, Research and Develo	AAward	+2,153 sh	—	—	2,153
2009-07-01	PROGENICS PHARMACEUTICALS INCM Exercise/Conversion	Senior VP, Research and Develo	MExercise/Conversion	+6,461 sh	$5.33	+$34.4K	42,352
2009-07-01	PROGENICS PHARMACEUTICALS INCF Tax Payment	Senior VP, Research and Develo	FTax Payment	−5,880 sh	$5.33	−$31.3K	36,472
2009-07-01	PROGENICS PHARMACEUTICALS INCESPP (right to buy)A Award	Senior VP, Research and Develo	AAward	+2,191 sh	—	—	2,191
2009-07-01	PROGENICS PHARMACEUTICALS INCESPP (right to buy)M Exercise/Conversion	Senior VP, Research and Develo	MExercise/Conversion	−6,461 sh	—	—	0
2009-07-01	PROGENICS PHARMACEUTICALS INCNon-Qualified Stock Option (right to buy)A Award	Senior VP, Research and Develo	AAward	+50K sh	—	—	50,000
2009-06-23	PROGENICS PHARMACEUTICALS INCS Sale	Senior VP, Research and Develo	SSale	−2,500 sh	$4.73	−$11.8K	35,677
2009-04-01	PROGENICS PHARMACEUTICALS INCF Tax Payment	Senior VP, Research and Develo	FTax Payment	−1,832 sh	$6.65	−$12.2K	36,163

Recent filings

Accepted (ET)
Apr 84
Olson William C0001447348-13-000015
SEC(opens sec.gov)
Jun 224
Olson William C0001447348-12-000037
SEC(opens sec.gov)
Mar 54
Olson William C0001447348-12-000016
SEC(opens sec.gov)
Oct 44
Olson William C0001441844-11-000044
SEC(opens sec.gov)
Jul 64
Olson William C0001441844-11-000029
SEC(opens sec.gov)
Jun 224
Olson William C0001441844-11-000024
SEC(opens sec.gov)
Apr 54
Olson William C0001441844-11-000014
SEC(opens sec.gov)
Jan 54
Olson William C0001441844-11-000002
SEC(opens sec.gov)

Companies

PROGENICS PHARMACEUTICALS INCSenior VP, Research and Develo

Address

777 OLD SAW MILL RIVER ROAD

TARRYTOWN, NY, 10591